Latest Ratings for LEGN
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 2022 | Morgan Stanley | Maintains | Overweight | |
| Jan 2022 | Morgan Stanley | Upgrades | Equal-Weight | Overweight |
| Jan 2022 | Morgan Stanley | Downgrades | Overweight | Equal-Weight |
Deep Dive Into Legend Biotech Stock: Analyst Perspectives (10 Ratings)
